| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 474,861 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 300,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 165,000 | - | - | View Details Filing |
| Feb 27, 2026 | Atrium Therapeutics, Inc. (RNA) | A | 20,000 | $0.00 | $0.00 | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 386,015 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 300,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 425,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 400,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 200,000 | - | - | View Details Filing |
| Jan 21, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 7,993 | $72.45 | $579,092.85 | View Details Filing |
| Jan 21, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 6,394 | $72.45 | $463,245.30 | View Details Filing |
| Jan 7, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 8,576 | $72.23 | $619,444.48 | View Details Filing |